Bisoprolol transdermal

Drug Profile

Bisoprolol transdermal

Alternative Names: Bisono Tape; TY-0201

Latest Information Update: 26 Apr 2017

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Nitto Denko; Toa Eiyo
  • Class Antihypertensives; Heart failure therapies; Ischaemic heart disorder therapies; Propanolamines; Small molecules
  • Mechanism of Action Beta 1 adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypertension
  • Phase III Atrial fibrillation
  • Phase II Heart failure

Most Recent Events

  • 19 Apr 2017 Toa Eiyo completes a phase III trial in Atrial fibrillation in Japan (JapicCTI152789)
  • 05 Jan 2017 Toa Eiyo completes a phase III trial in Atrial fibrillation in Japan (Transdermal) (JapicCTI-142700)
  • 13 Aug 2016 Toa Eiyo completes a clinical trial in Healthy volunteers in Japan (Transdermal) (UMIN000022622)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top